Acasti Pharma (FRA:A1P0) Days Sales Outstanding : 0.00 (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Acasti Pharma Days Sales Outstanding?

Acasti Pharma's average Accounts Receivable for the three months ended in Dec. 2023 was €0.00 Mil. Acasti Pharma's Revenue for the three months ended in Dec. 2023 was €0.00 Mil.

The historical rank and industry rank for Acasti Pharma's Days Sales Outstanding or its related term are showing as below:

During the past 13 years, Acasti Pharma's highest Days Sales Outstanding was 213.32. The lowest was 45.43. And the median was 129.38.

FRA:A1P0's Days Sales Outstanding is not ranked ^*
in the Biotechnology industry.
Industry Median: 73.24
* Ranked among companies with meaningful Days Sales Outstanding only.

Acasti Pharma's Days Sales Outstanding stayed the same from Dec. 2022 (0.00) to Dec. 2023 (0.00).

Acasti Pharma Days Sales Outstanding Historical Data

The historical data trend for Acasti Pharma's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acasti Pharma Days Sales Outstanding Chart

Acasti Pharma Annual Data

Trend

Feb13

Feb14

Feb15

Feb16

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Days Sales Outstanding

Get a 7-Day Free Trial

Acasti Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Acasti Pharma's Days Sales Outstanding

For the Biotechnology subindustry, Acasti Pharma's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Acasti Pharma's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Acasti Pharma's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Acasti Pharma's Days Sales Outstanding falls into.

Acasti Pharma Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Acasti Pharma's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

	Days Sales Outstanding (A: Mar. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2022 )	+	Accounts Receivable (A: Mar. 2023 ))	/	count )	/	Revenue (A: Mar. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

Acasti Pharma's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 4
=	0					/	0	*	365 / 4
=	N/A

Acasti Pharma (FRA:A1P0) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Acasti Pharma Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Acasti Pharma's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Acasti Pharma (FRA:A1P0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acasti Pharma Inc (FRA:A1P0) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

ACST:USA A1P0:Germany

Address

3009 Boulevard de la Concorde East, Suite 102, Laval, QC, CAN, H7E 2B5

Website

https://www.acastipharma.com

Acasti Pharma Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. Its novel drug delivery technologies have the potential to improve the performance of marketed drugs by achieving faster onset of action, enhanced efficacy, reduced side effects, and more convenient drug delivery all of which could help to increase treatment compliance and improve patient outcomes.

Acasti Pharma (FRA:A1P0) Headlines

No Headlines